 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: OCREVUS (ocrelizumab) |
|
***************************************************** |
|
#Post#: 4749-------------------------------------------------- |
|
(ACTRIMS abst.) MS patients treated with ocrelizumab, aged 70 an |
|
d older... |
|
By: agate Date: March 22, 2025, 1:14 am |
|
--------------------------------------------------------- |
|
Presented at the annual ACTRIMS forum for 2025, "Multiple |
|
sclerosis patients treated with ocrelizumab, aged 70 and older: |
|
A retrospective cohort study": |
|
https://www.abstractsonline.com/pp8/#!/20973/presentation/644 |
|
This link might not work if you are not registered on the |
|
ACTRIMS Website. Registration is not difficult. |
|
#Post#: 4787-------------------------------------------------- |
|
(AAN abst.) Adults 55 years and older w/MS treated w/ocrelizumab |
|
... |
|
By: agate Date: April 27, 2025, 7:01 pm |
|
--------------------------------------------------------- |
|
The authors of the study previously noted in this thread have |
|
also presented findings at the April AAN annual meeting--with an |
|
abstract entitled "Adults 55 years and older with MS treated |
|
with ocrelizumab: Characteristics and outcomes over more than |
|
13,000 person-months": |
|
https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-003335.html |
|
***************************************************** |
